Abstract
Sepsis is not a monolithic disease, but a loose collection of symptoms with a diverse range of outcomes. The diverse patterns of sepsis make guideline-driven treatment difficult, as guidelines are based on the needs of the “average” patient. Thus, stratification and subtyping of sepsis patients is of interests, with the ultimate goal of identifying groups of patients who respond similarly to treatment. To do this, we examine the temporal evolution of patient state using our previously-published method for computing patient risk of transition into septic shock. The application of spectral clustering to risk score trajectories reveals that these trajectories diverge into four distinct clusters in the time window following early prediction of septic shock. Patients in these clusters stratify by outcome: the highest-risk group has a 76.5% prevalence of septic shock and 43% mortality, whereas the lowest-risk group has a 10.4% prevalence of septic shock and 18% mortality. These clusters differ also in treatments received, as well as median time to septic shock onset. Data analyses reveal the existence of a rapid (30-60 min) transition in risk at the time of threshold crossing. We hypothesize that this rapid transition occurs as a result of an abrupt failure of compensatory biological systems to cope with infection, resulting in a bifurcation of low to high risk. Such a collapse in compensation, we believe, represents the true onset of septic shock. Thus, what we previously referred to as the pre-shock state represents a potential new data-driven definition of septic shock.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Work supported by NSF EECS 1609038 and NIH UL1 TR001079.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in this study was obtained solely from the publicly available eICU database.